Brian Winne

Each week we highlight five things affecting the life sciences industry. Here's the latest. Addressing clinical trials challenges in biopharma ecosystem Experts at the Outsourcing in Clinical Trials Conference in New England discussed strategies for navigating the challenging biopharma ecosystem, ... READ MORE >

Each week we highlight five things affecting the life sciences industry. Here's the latest. UK Parliament considering new post-market surveillance regulations The UK government has introduced new regulations for post-market surveillance of medical devices, aiming to enhance patient safety and device ... READ MORE >

Each week we highlight five things affecting the life sciences industry. Here's the latest. New antibody discovery software unveiled Dotmatics, a research and development software provider, is launching a platform for therapeutic antibody discovery that integrates sequence visualization, antibody ... READ MORE >

 Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves at-home COVID/flu combo test for fall season The U.S. Food and Drug Administration has approved an at-home test by Healgen that detects both COVID-19 and influenza A and B, marking a significant ... READ MORE >

Each week we highlight five things affecting the life sciences industry. Here's the latest. Federal government prolongs reimbursement cuts for lab services Congress has delayed Medicare reimbursement cuts for lab services by passing a short-term funding bill, postponing the implementation of new ... READ MORE >

Each week we highlight five things affecting the life sciences industry. Here's the latest. Many FDA-authorized AI devices lack validation data Over 40% of artificial intelligence-enabled medical devices cleared by the U.S. Food and Drug Administration lack clinical validation data, according to a ... READ MORE >